Akt/mTOR Role in Human Foetoplacental Vascular Insulin Resistance in Diseases of Pregnancy
Open Access
- 14 September 2017
- journal article
- review article
- Published by Wiley in Journal of Diabetes Research
- Vol. 2017, 1-13
Abstract
Insulin resistance is characteristic of pregnancies where the mother shows metabolic alterations, such as preeclampsia (PE) and gestational diabetes mellitus (GDM), or abnormal maternal conditions such as pregestational maternal obesity (PGMO). Insulin signalling includes activation of insulin receptor substrates 1 and 2 (IRS1/2) as well as Src homology 2 domain-containing transforming protein 1, leading to activation of 44 and 42 kDa mitogen-activated protein kinases and protein kinase B/Akt (Akt) signalling cascades in the human foetoplacental vasculature. PE, GDM, and PGMO are abnormal conditions coursing with reduced insulin signalling, but the possibility of the involvement of similar cell signalling mechanisms is not addressed. This review aimed to determine whether reduced insulin signalling in PE, GDM, and PGMO shares a common mechanism in the human foetoplacental vasculature. Insulin resistance in these pathological conditions results from reduced Akt activation mainly due to inhibition of IRS1/2, likely due to the increased activity of the mammalian target of rapamycin (mTOR) resulting from lower activity of adenosine monophosphate kinase. Thus, a defective signalling via Akt/mTOR in response to insulin is a central and common mechanism of insulin resistance in these diseases of pregnancy. In this review, we summarise the cell signalling mechanisms behind the insulin resistance state in PE, GDM, and PGMO focused in the Akt/mTOR signalling pathway in the human foetoplacental endothelium.Keywords
Funding Information
- Marie Curie International Research Staff Exchange Scheme (295185, 11150083, 3160194, 1150344, 1150377)
- Fondo Nacional de Desarrollo Científico y Tecnológico (295185, 11150083, 3160194, 1150344, 1150377)
- Fondo Nacional de Desarrollo Científico y Tecnológico (295185, 11150083, 3160194, 1150344, 1150377)
- Fondo Nacional de Desarrollo Científico y Tecnológico (295185, 11150083, 3160194, 1150344, 1150377)
- Fondo Nacional de Desarrollo Científico y Tecnológico (295185, 11150083, 3160194, 1150344, 1150377)
This publication has 119 references indexed in Scilit:
- Higher Fetal Insulin Resistance in Chinese Pregnant Women with Gestational Diabetes Mellitus and Correlation with Maternal Insulin ResistancePLOS ONE, 2013
- Impaired A2A adenosine receptor/nitric oxide/VEGF signaling pathway in fetal endothelium during late- and early-onset preeclampsiaPurinergic Signalling, 2012
- Birth-weight, insulin levels, and HOMA-IR in newborns at termBMC Pediatrics, 2012
- Serum leptin levels in relation to circulating cytokines, chemokines, adhesion molecules and angiogenic factors in normal pregnancy and preeclampsiaReproductive Biology and Endocrinology, 2011
- The AMPK signalling pathway coordinates cell growth, autophagy and metabolismNature Cell Biology, 2011
- Loss of Akt activity increases circulating soluble endoglin release in preeclampsia: identification of inter-dependency between Akt-1 and heme oxygenase-1European Heart Journal, 2011
- Angiogenic Factors and PreeclampsiaSeminars in Nephrology, 2011
- Soluble FLT1 sensitizes endothelial cells to inflammatory cytokines by antagonizing VEGF receptor-mediated signallingCardiovascular Research, 2010
- Fasting Plasma Leptin Level Is a Surrogate Measure of Insulin SensitivityThe Journal of Clinical Endocrinology & Metabolism, 2010
- Raptor Binds the SAIN (Shc and IRS-1 NPXY Binding) Domain of Insulin Receptor Substrate-1 (IRS-1) and Regulates the Phosphorylation of IRS-1 at Ser-636/639 by mTORJournal of Biological Chemistry, 2009